Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Inflammatory eye disorders
How do you manage a patient with idiopathic bilateral anterior uveitis who is well controlled on Acthar Gel but is planning pregnancy?
Would you recommend transitioning to a TNF inhibitor?
Related Questions
How do you approach the management of a patient with psoriasis and chronic anterior uveitis who is unable to take DMARDs and has tried TNF inhibitors and IL-17 inhibitors but has ongoing bilateral anterior uveitis?
What is your algorithm for transitioning a patient with chronic noninfectious posterior uveitis from corticosteroids to immunosuppressive therapy?
When would you consider discontinuing immunosuppressive treatment in a quiescent uveitis patient without systemic manifestations of inflammation?
How often do you recommend ophthalmologic screening exams for patients with sarcoidosis?
How do you taper corticotropin injections (Acthar) in patients with rheumatologic disease?
Would you add a DMARD such as methotrexate for a patient with GCA and partial response to tocilizumab but inability to taper prednisone below 10mg daily?
When stopping denosumab and transitioning to PO bisphosphonate, do you wait for 6 months after the last denosumab injection to start PO bisphosphonate?
How do you approach evaluation of a patient with symmetric length dependent axonal sensorimotor neuropathy and +ANA but no current signs or symptoms of rheumatologic disease?
What are your thoughts on telitacicept use in SLE, and why has it not garnered more attention in US news cycle in rheumatology?
How do you decide when to use acid-suppressive medications for GI prophylaxis when patients are on prolonged corticosteroid therapy?